Yi Hu

2.5k total citations
72 papers, 1.6k citations indexed

About

Yi Hu is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yi Hu has authored 72 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Surgery, 23 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in Yi Hu's work include Helicobacter pylori-related gastroenterology studies (35 papers), Gastric Cancer Management and Outcomes (17 papers) and Veterinary medicine and infectious diseases (10 papers). Yi Hu is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (35 papers), Gastric Cancer Management and Outcomes (17 papers) and Veterinary medicine and infectious diseases (10 papers). Yi Hu collaborates with scholars based in China, United States and Hong Kong. Yi Hu's co-authors include Yin Zhu, Nonghua Lü, Yaobin Ouyang, Cong He, Nonghua Lü, Chuan Xie, Nianshuang Li, Chao Peng, Zhongming Ge and David Y. Graham and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.

In The Last Decade

Yi Hu

70 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Hu China 24 909 369 365 272 245 72 1.6k
Masakatsu Nakamura Japan 26 929 1.0× 415 1.1× 805 2.2× 601 2.2× 388 1.6× 125 2.4k
Zijian Pan China 14 295 0.3× 70 0.2× 240 0.7× 332 1.2× 54 0.2× 35 916
Min Kyoung Kim South Korea 26 304 0.3× 282 0.8× 606 1.7× 328 1.2× 122 0.5× 107 2.3k
Mohammad Javad Ashraf Iran 21 458 0.5× 166 0.4× 364 1.0× 105 0.4× 11 0.0× 173 1.6k
Mi Kyung Kim South Korea 16 234 0.3× 110 0.3× 144 0.4× 60 0.2× 43 0.2× 89 858
Colin de Haar Netherlands 24 314 0.3× 131 0.4× 569 1.6× 1.0k 3.8× 46 0.2× 46 2.3k
Fabio Munari Italy 15 328 0.4× 179 0.5× 773 2.1× 1.1k 4.0× 15 0.1× 22 2.2k
Wei Qian China 24 185 0.2× 82 0.2× 934 2.6× 170 0.6× 99 0.4× 61 1.6k
Kirstin Atrott Switzerland 21 230 0.3× 70 0.2× 913 2.5× 493 1.8× 44 0.2× 48 1.6k
Feride İffet Şahin Türkiye 20 303 0.3× 107 0.3× 379 1.0× 97 0.4× 11 0.0× 133 1.4k

Countries citing papers authored by Yi Hu

Since Specialization
Citations

This map shows the geographic impact of Yi Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Hu more than expected).

Fields of papers citing papers by Yi Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Hu. The network helps show where Yi Hu may publish in the future.

Co-authorship network of co-authors of Yi Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Hu. A scholar is included among the top collaborators of Yi Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Hu. Yi Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yanan, Nianshuang Li, Ziwen He, et al.. (2025). Helicobacter pylori activates DOPEY1 to promote p53 degradation through the USP7/TRIP12 axis in gastric tumorigenesis. Oncogene. 44(18). 1245–1258. 2 indexed citations
3.
5.
Ouyang, Yaobin, et al.. (2023). Research trends on vonoprazan‐based therapy for Helicobacter pylori eradication: A bibliometric analysis from 2015 to 2023. Helicobacter. 28(5). e13012–e13012. 5 indexed citations
6.
Wang, Menghui, et al.. (2023). TikTok and Bilibili as sources of information on Helicobacter pylori in China: A content and quality analysis. Helicobacter. 28(5). e13007–e13007. 30 indexed citations
7.
Hu, Yi, Yaobin Ouyang, Cong He, et al.. (2022). Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan‐amoxicillin dual therapy for Helicobacter pylori eradication. Helicobacter. 27(5). e12923–e12923. 8 indexed citations
8.
Ouyang, Yaobin, et al.. (2022). Amoxicillin‐vonoprazan dual therapy forHelicobacter pylorieradication: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology. 37(9). 1666–1672. 37 indexed citations
9.
Chen, Hongyan, Yi Hu, Xinbo Xu, et al.. (2021). Upregulation of oncogene Activin A receptor type I by Helicobacter pylori infection promotes gastric intestinal metaplasia via regulating CDX2. Helicobacter. 26(6). e12849–e12849. 11 indexed citations
10.
Li, Nianshuang, et al.. (2021). Discovery and Validation of Novel Methylation Markers in Helicobacter pylori-Associated Gastric Cancer. Disease Markers. 2021. 1–11. 6 indexed citations
11.
Feng, Wenjing, Jianya Liu, Shan Wang, et al.. (2021). Alginate oligosaccharide alleviates D‐galactose‐induced cardiac ageing via regulating myocardial mitochondria function and integrity in mice. Journal of Cellular and Molecular Medicine. 25(15). 7157–7168. 36 indexed citations
12.
Hu, Yi, Yaobin Ouyang, Yin Zhu, & Nonghua Lü. (2021). Reverse hybrid therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis. Helicobacter. 26(2). e12784–e12784. 5 indexed citations
13.
Chen, Hongyan, Yi Hu, Nonghua Lü, & Yin Zhu. (2020). Caudal type homeoboxes as a driving force in Helicobacter pylori infection-induced gastric intestinal metaplasia. Gut Microbes. 12(1). 1809331–1809331. 21 indexed citations
14.
Xie, Chuan, Nianshuang Li, Huan Wang, et al.. (2020). Inhibition of autophagy aggravates DNA damage response and gastric tumorigenesis via Rad51 ubiquitination in response to H. pylori infection. Gut Microbes. 11(6). 1567–1589. 53 indexed citations
15.
Li, Xue-Yang, Yi Hu, Nianshuang Li, et al.. (2019). RACK1 Acts as a Potential Tumor Promoter in Colorectal Cancer. Gastroenterology Research and Practice. 2019. 1–8. 9 indexed citations
16.
Hu, Yi, Jianping Liu, Xue-Yang Li, et al.. (2019). Downregulation of tumor suppressor RACK1 by Helicobacter pylori infection promotes gastric carcinogenesis through the integrin β-1/NF-κB signaling pathway. Cancer Letters. 450. 144–154. 30 indexed citations
17.
Peng, Chao, Nianshuang Li, Yi Hu, & Nonghua Lü. (2019). Impact factors that modulate gastric cancer risk in Helicobacter pylori‐infected rodent models. Helicobacter. 24(4). e12580–e12580. 9 indexed citations
19.
Hu, Yi, et al.. (2017). Systematic review with meta‐analysis: the global recurrence rate of Helicobacter pylori. Alimentary Pharmacology & Therapeutics. 46(9). 773–779. 107 indexed citations
20.
Zhu, Yin, Yi Hu, Ming Cheng, et al.. (2017). Establishment and Characterization of a Nude Mouse Model of Subcutaneously Implanted Tumors and Abdominal Metastasis in Gastric Cancer. Gastroenterology Research and Practice. 2017. 1–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026